Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lung disease
Phenotype C0011644|scleroderma
Sentences 9
PubMedID- 21314931 The aim of the study was to investigate the presence of thymosins beta4, beta4 sulfoxide, and beta10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters.
PubMedID- 25110305 Good outcome of interstitial lung disease in patients with scleroderma associated to anti-pm/scl antibody.
PubMedID- 22723597 Up-regulated expression of hla-drb5 transcripts and high frequency of the hla-drb5*01:05 allele in scleroderma patients with interstitial lung disease.
PubMedID- 21552414 Background: scleroderma (ssc) patients with active interstitial lung disease (ild) experience a decline in lung function and increased mortality; cyclophosphamide (cyc) therapy may stabilize lung function at one and two years follow-up.
PubMedID- 22826062 Interstitial lung disease often coexists with scleroderma and is accompanied by functional lung abnormalities.
PubMedID- 20352228 To evaluate the role and the prognostic value of bronchoalveolar lavage (bal) in scleroderma patients with interstitial lung disease.
PubMedID- 22402140 This study aimed to evaluate vegf concentration in the bronchoalveolar lavage fluid (balf) of scleroderma patients with interstitial lung disease, to correlate the cytokine levels in plasma and in the lung with pulmonary functional, radiological and cellular parameters, and with the progression of lung disease.
PubMedID- 23092273 Indeed pulmonary hypertension secondary to scleroderma or other types of inflammatory lung disease has a far worse prognosis and appears to impact the rv more profoundly than more conventional types of pulmonary hypertension.
PubMedID- 24627847 A case of sine scleroderma with parenchymal lung disease.

Page: 1